Hemenway Trust Hemenway Trust’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.54M Buy
123,728
+60,648
+96% +$4.19M 0.66% 36
2025
Q1
$4.38M Buy
63,080
+52,324
+486% +$3.63M 0.36% 43
2024
Q4
$925K Sell
10,756
-200
-2% -$17.2K 0.08% 65
2024
Q3
$1.3M Sell
10,956
-432
-4% -$51.4K 0.1% 60
2024
Q2
$1.63M Hold
11,388
0.14% 53
2024
Q1
$1.46M Hold
11,388
0.13% 54
2023
Q4
$1.18M Buy
11,388
+1,818
+19% +$188K 0.11% 57
2023
Q3
$870K Sell
9,570
-234
-2% -$21.3K 0.09% 69
2023
Q2
$793K Buy
9,804
+5,790
+144% +$468K 0.08% 75
2023
Q1
$319K Hold
4,014
0.03% 109
2022
Q4
$272K Buy
+4,014
New +$272K 0.03% 119
2016
Q1
Sell
-7,084
Closed -$206K 151
2015
Q4
$206K Sell
7,084
-940
-12% -$27.3K 0.05% 149
2015
Q3
$218K Buy
+8,024
New +$218K 0.06% 146